NVN1000: Completed Phase IIb enrollment

Novan completed enrollment of 200 patients with moderate to severe acne vulgaris in a double-blind, vehicle-controlled, U.S. Phase IIb trial evaluating SB204 gel for up to 12 weeks. Patients will rece...